2021
DOI: 10.1101/2021.09.17.460782
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The nuts and bolts of SARS-CoV-2 Spike Receptor Binding Domain heterologous expression

Abstract: COVID-19 is a highly infectious disease caused by a newly emerged coronavirus (SARS-CoV-2) that has rapidly progressed into a pandemic. This unprecedent emergency has stressed the significance of developing effective therapeutics to fight current and future outbreaks. The receptor-binding domain (RBD) of the SARS-CoV-2 surface Spike protein is the main target for vaccines and represents a helpful tool to produce neutralizing antibodies or diagnostic kits. In this work, we provide a detailed characterization of… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 44 publications
(41 reference statements)
0
8
0
Order By: Relevance
“…coli-expressed S1 [28]. E. coli-expressed non-glycosylated RBD protein was previous ly demonstrated to elicit approximately 7-fold lower binding by immunised rat serum IgG at 5 µg/mL in an ELISA compared to glycosylated RBD expressed in insect (Sf21) and HEK cells [40]. At lower concentrations, binding to E. coli-expressed RBD was below the assay threshold.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…coli-expressed S1 [28]. E. coli-expressed non-glycosylated RBD protein was previous ly demonstrated to elicit approximately 7-fold lower binding by immunised rat serum IgG at 5 µg/mL in an ELISA compared to glycosylated RBD expressed in insect (Sf21) and HEK cells [40]. At lower concentrations, binding to E. coli-expressed RBD was below the assay threshold.…”
Section: Discussionmentioning
confidence: 99%
“…Proteins recombinantly expressed in E. coli are missing post-translational modificatio ns (PTMs) while those expressed in mammalian and insect cells can have PTMs, includ ing glycosylation, but the PTMs and glycosylation will vary depending on the system used with consequent impacts on protein functionality [40]. In human infections, the SARS-CoV-2 S protein is very heavily glycosylated with both high mannose and complex type N -linked glycosylation and O-linked glycosylation, which shields much of the viral protein backbone from host immune recognition including the enfolded RBD [41,42].…”
Section: Antigen Glycosylation Influences Serum Antibody Recognitionmentioning
confidence: 99%
“…Spectra of the WT match those reported in the literature. 10,[37][38][39] More importantly, none of the mutations caused significant changes in the spectra, implying that the Delta mutations do not affect the global protein structure of RBD.…”
Section: None Of the Delta Mutations Significantly Affect Global Prot...mentioning
confidence: 99%
“…Since the beginning of the 2019 SARS-CoV-2 pandemic, RBD that is the key domain for human cell infection [ 19 , 20 ] has attracted much attention as a target molecule for treatment utilizing neutralizing antibodies [ 21 , 22 ] and vaccines [ 23 ]. In this context, recombinant expression of RBD in E. coli has been attempted; however, expression without the presence of any solubility-enhancing tag within the soluble fraction and with correct folding has not yet been achieved [ [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] ]. RBD possesses four disulfide bonds [ 33 ] that make it difficult for this domain to fold correctly.…”
Section: Introductionmentioning
confidence: 99%
“…RBD possesses four disulfide bonds [ 33 ] that make it difficult for this domain to fold correctly. Although many attempts have been made to refold RBDs from inclusion bodies, the procedure is complicated, and it has been suggested that the physicochemical properties may differ from those of proteins produced by baculovirus or by mammalian cell expression systems [ 31 ]. Although the RBD-MBP fusion protein was reported to be expressed in the soluble fraction of the cytoplasm [ 32 ], there was no structural or physicochemical information for the recombinant fusion protein except for information regarding ACE2 binding ability, and it may be possible that untagged RBD is insoluble when MBP is cleaved due to the strong solubilizing effect of MBP [ 34 ].…”
Section: Introductionmentioning
confidence: 99%